Kacerovský M, Tosner J
Lékarská fakulta Hradec Králové, Univerzita Karlova, Praha.
Ceska Gynekol. 2009 Aug;74(4):274-8.
The purpose of this study was to focuse on recent developments on the evolving field of biomarker discovery and validation techniques using proteomics platforms for endometrial carcinoma.
Review.
Department of Obstetrics and Gynecology Medical Faculty Charles University Hradec Kralove.
The last decade has seen major changes in the technologies used to identify markers for diagnosing endometrial carcinoma. Currently the major developments were made in proteomics area. This new technology hold significant promise in identifying more robust markers for endometrial carcinoma.
The present review summarizes the results of clinical and experimental research on biomarkers of endometrial carcinoma.
本研究旨在聚焦于使用蛋白质组学平台进行子宫内膜癌生物标志物发现和验证技术这一不断发展领域的最新进展。
综述。
布拉格克拉洛韦大学医学院妇产科。
在用于识别子宫内膜癌诊断标志物的技术方面，过去十年发生了重大变化。目前，主要进展是在蛋白质组学领域取得的。这项新技术在识别更可靠的子宫内膜癌标志物方面具有巨大潜力。
本综述总结了子宫内膜癌生物标志物的临床和实验研究结果。
